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Abstract
Few studies have examined the relative risk of recurrence of different stone types. The object of the present study was to 
evaluate the tendency for stone recurrence as a function of major mineral composition of the stones and morphological 
characteristics of the stones. This study was carried out using 38,274 stones for which we had data available to specify if the 
stone was from the first or a subsequent urinary stone episode. Stones were analyzed for morphology by stereomicroscope 
and for composition by infrared spectroscopy. Overall, 42.7% of stones were from patients who had had a previous stone 
event, with these being more frequent in men (44.4%) than in women (38.9%, p < 0.0001). Age of first stone occurrence was 
lowest for dihydroxyadenine (15.7 ± 16.6 years) and highest for anhydrous uric acid (62.5 ± 14.9 years), with the average age 
of first stones of calcium oxalate falling in the middle (40.7 ± 14.6 years for calcium oxalate dihydrate, and 48.4 ± 15.1 years 
for calcium oxalate monohydrate, COM). By composition alone, COM was among the least recurrent of stones, with only 
38.0% of COM stones coming from patients who had had a previous episode; however, when the different morphological 
types of COM were considered, type Ic—which displays a light color, budding surface and unorganized section—had a 
significantly greater rate of recurrence, at 82.4% (p < 0.0001), than did other morphologies of COM. Similarly, for stones 
composed of apatite, morphological type IVa2—a unique form with cracks visible beneath a glossy surface—had a higher 
rate of recurrence than other apatite morphologies (78.8 vs. 39–42%, p < 0.0001). Stone mineral type alone is insufficient 
for identifying the potential of recurrence of the stones. Instead, the addition of stone morphology may allow the diagnosis 
of highly recurrent stones, even among common mineral types (e.g., COM) that in general are less recurrent.
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Introduction
Epidemiological studies on rates of stone occurrence and 
recurrence in industrialized countries agree on two points: 
first, urinary stones strike men more often than women 
and, second, recurrence of at least one more stone occurs 
in 40–50% of affected persons [1–3]. However, few studies 
have examined the relative risk of recurrence of different 
stone types. It seems reasonable to state that cystine stone 
disease, because of its genetic basis, leads to greater stone 
recurrence than most other types of stone disease [4]. Simi-
larly, uric acid stones in older patients are often quite recur-
rent [5]. However, it is not so clear what to say about the 
stones composed of calcium salts. For calcium oxalate, stud-
ies from some years ago suggest that weddellite (calcium 
oxalate dihydrate, COD) stones are more likely to recur than 
whewellite (calcium oxalate monohydrate, COM) stones 
[6], and that stones with a significant component of calcium 
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phosphate are more likely to recur than stones composed of 
pure calcium oxalate [7]. The object of the present study was 
to evaluate the tendency for stone recurrence as a function of 
the major mineral composition of the stones, but also to take 
into account the morphological characteristics of the stones 
and the sex of the patient.
Materials and methods
This study was carried out using 38,274 stones collected 
from all regions of France for which we have data on both 
stone recurrence and the patient’s age at the first stone epi-
sode. The stones were analyzed for morphology and com-
position (by infrared spectroscopy, as previously described 
[8, 9]). Briefly, stones were examined using a stereomicro-
scope and each was classified according to the established 
morphological criteria [9, 10]. These criteria include the 
appearance of the stone surface but also the appearance of 
the stone interior after the stone was cleaved one or more 
times to reveal its presumed nidus. The main characteristics 
of the stones are summarized in Table 1 and some examples 
of stone types are given in Fig. 1. Following these visual 
observations, samples of stone material were dissected away 
for analysis by Fourier transform infrared spectroscopy. For 
each stone, patient data were available to specify if this was 
from the first or a subsequent stone episode. The results are 
expressed according to the principal constituent, morpho-
logical type, and structural characteristics of the stone, and 
separated according to the sex of the patient.
Statistical comparisons were carried out using ANOVA 
and Chi-squared tests, as appropriate, using NCSS software 
(NCSS, Kaysville, Utah, USA).
Results
Of the 38,274 stones, coming from 26,368 males (68.9%) 
and 11,906 females, 16,336 (42.7%) were from patients 
who had had a previous stone event. Of these patients with 
recurrent stones, 11,702 were male and 4634 female, illus-
trating the fact that recurrent stones were more frequent in 
men than in women (44.4 vs 38.9% of the total for each sex, 
p < 0.0001). The mean age of patients with recurrent stones 
did not differ between the sexes (45.0 ± 14.3 years old for 
men, 44.0 ± 14.8 for women).
Mean age at first stone as a function of stone 
mineral
We first consider the data on patients’ initial stone events, 
looking at the age of first stone occurrence for the different 
crystalline species. The data are shown in Table 2, where, for 
each majority stone component, the mean age of the patients 
is given for each sex, with the stone components listed 
according to the increasing mean age of first occurrence. It 
is striking that the first five compositions listed in Table 2—
that is, the stone types occurring at the earliest ages—are 
crystalline species that are relatively rare, representing < 5% 
of all stones [10, 11]. We are aware that the small number 
of samples in these groups is a limiting factor for the sig-
nificance of the data regarding these stones. However, as 
expected, due to their inherited origin, the first groups of 
calculi are dihydroxyadenine and cystine. The crystalline 
species occurring at the youngest age is dihydroxyadenine. 
The second species is cystine, followed by octacalcium 
phosphate and whitlockite, then ammonium urate. Coming 
next in the table are more common types of stone, the first of 
which is COD, the calcium-dependant type of calcium oxa-
late [12–14]. The mean age at which this crystalline species 
appeared as a stone was 40 years, eight years younger than 
the mean age for COM stones, the other form of calcium 
oxalate. The distribution of calcium oxalate stones according 
to the crystalline phase and the patient’s age and gender at 
the onset of the disease is illustrated in Fig. 2.
Between COD and COM are four forms of phosphate 
stone. Finally, the species appearing latest in life are the 
two forms of uric acid. The distribution of uric acid stones 
according to the patient’s age and gender at the onset of the 
disease is shown in Fig. 3.
Frequency of stone recurrence as a function 
of principal component
Table 3 shows the proportion of patients having a recurrent 
stone episode (that is, the second or later stone episode for 
the patient) for each principal stone component. Within this, 
the stone components are ranked according to the increasing 
proportion of recurrent stones. Among the stone mineral 
types that have the lowest percentage of recurrence, two 
are phosphate stones, including struvite. However, among 
the seldom-recurring stones is also COM, the constituent 
most commonly found in urinary stones [10, 15, 16]. All the 
stone compositions that follow struvite in the table—with 
the exception of COD in men and women, and carbapatite 
and octacalcium phosphate in women—are more recurrent 
than the average percentage for all stones. Among these 
more-recurrent compositions, the two forms of uric acid 
appear at the head with a percentage of recurrence above 
50%, significantly higher than the average percentage for all 
stones. Finally, the three species at the bottom of Table 3 are 
particularly recurrent, apparently all forms of stone caused 
by very active metabolic processes: These are brushite, cys-
tine, and dihydroxyadenine.
For stones of calcium oxalate, brushite and cystine, we 
have also recorded the number of stone episodes in the 
patients with recurrent stones. The patients who produced 
calcium oxalate stones had a mean of 3.5 stone episodes, 
while that number exceeded 7.5 for both brushite and 
cystine. This number is probably even higher for patients 
with uric acid stones, but it is difficult to evaluate with pre-
cision, as these patients often repeatedly form sand and/or 
Table 1  Morphoconstitutional classification of urinary calculi (from [9, 10])
Morphological type Subtype Main components Main morphological characteristics (for more details, see [9, 10])
Surface Section
I Ia Whewellite Mammillary, brown Concentric, radiating organization, 
brown
Ib Whewellite Rough and mammillary, brown Unorganized, brown
Ic Whewellite Budding, cream to pale yellow–brown Poorly organized, cream to pale yel-
low–brown
Id Whewellite Smooth, beige or pale brown Concentric, compact, beige
Ie Whewellite Locally budding and mammillary, 
pale yellow–brown to brown
Locally unorganized, locally radiating 
organization, pale yellow–brown to 
brown
II IIa Weddellite Bipyramidal crystals aggregated, with 
sharp angles and ridges, pale yellow
Loose radial organization, pale yellow
IIb Weddellite ± whewellite Bipyramidal crystals aggregated, 
with blunted angles and ridges, pale 
yellow
Unorganized, pale yellow
IIc Weddellite Rough, grey-beige Thin layers in periphery, unorganized 
core, grey-beige
III IIIa Uric acid Smooth, ochre to orange Concentric, radiating organization, 
orange
IIIb Uric acid Embossed, rough and porous, beige 
to orange
Unorganized or poorly organized and 
porous, orange
IIIc Various urates Rough, locally porous, beige to grey-
ish
Unorganized with porous areas, beige 
to greyish
IIId Ammonium urate Embossed, rough and porous, grey-
brown
Alternated layers, thick and brownish, 
thin and greyish
IV IVa1 Carbapatite Rough or slightly embossed, cream 
to beige
Poorly organized, whitish to cream
IVa2 Carbapatite Embossed, glazed with cracks, yel-
low–brown
Alternated layers, thick and yellow–
brown, thin and cream
IVb Carbapatite Heterogenous, both embossed and 
rough
Heterogenous color, cream to brown
Alternated layers, thick and cream, thin 
and yellow–brown
IVc Struvite Amalgamate crystals with blunted 
angles and thick ridges, whitish
Crude radial crystallization, whitish
IVd Brushite Finely rough or aggregated rods, 
cream to beige
Concentric, radiating organization, 
cream to beige
V Va Cystine Rough or grainy, yellowish Poorly organized, loose radiating 
organization, yellowish
Vb Cystine Smooth, cream to pale yellowish Concentric in periphery, unorganized 
core, cream to yellow
VI VIa Proteins Smooth, cream to pale brown Unorganized, cream to pale brown
VIb Proteins Rough and flaked off, dark brown to 
black
Crude and diffuse foliated structure, 
dark brown to black
VIc Proteins Homogenous, smooth, dark brown Soft concentric dark-brown shell, unor-
ganized beige core
Main mixed types
 Ia + IIa and Ia + IIb Whewellite + weddellite
 IIa + IVa1 and IIb + IVa1 Weddellite + carbapatite
 Ia + IIa + IVa1 Whewellite + weddellite + carbapatite
very small stones that are passed spontaneously with limited 
clinical symptoms. Moreover, in contrast to other crystalline 
species, stones composed of uric acid can be dissolved by 
urinary alkalization [17].
Frequency of stone recurrence as a function of stone 
morphology
The frequency of stone recurrence varied with morphologi-
cal type (Table 4; Fig. 4). This was especially apparent in 
calcium oxalate stones where the recurrence rate varied 
among morphological types from 27 to 82%, and in cal-
cium phosphate stones, where the recurrence rate varied 
from 39 to 79% among the different morphological types. 
Overall, the recurrence rate of COM was relatively low 
(Table 3), but the morphological types Ie, and especially Ic, 
had higher rates of recurrence (Fig. 4). Thus, recognition of 
these morphological types of COM in a patient could alert 
the physician to the possibility of a greater chance of stone 
recurrence.
Fig. 1  Photographs of the 
stone surface for the main 
morphological types of urinary 
calculi. Photographs a– d pure 
COM stones. Photograph e 
pure COD stone. Photograph 
f COD (75%) + COM (25%). 
Photographs g and h pure 
uric acid stones. Photograph i 
pure ammonium urate stone. 
Photograph j calcium phos-
phate stone made of a mixture 
of carbapatite (80%) and of 
amorphous carbonated calcium 
phosphate (20%). Photograph k 
nearly pure calcium phosphate 
stone: carbapatite (95%) + COD 
(5%). Photograph l carbapatite 
(50%) + struvite (40%) + amor-
phous carbonated calcium 
phosphate (10%). Photograph 
m struvite (90%) + carbapatite 
(10%). Photograph n brushite 
(90%) + COD (5%) + carbapatite 
(5%). Photograph o mixture of 
COM (70%) and COD (30%)
Type Ia Type Ic Type Id
Type Ie Type IIa Type IIb
Type IIIa Type IIIb Type IIIc
Type IVa1 Type IVa2 Type IVb
Type IVc Type IVd Mixed type Ia+IIa
A B C
D E F
G H I
J K L
M N O
For stones containing mainly COD (type II), the per-
centage of stones that were recurrent was generally not dif-
ferent from the mean of all stones, except for type Ia + IIb 
(mixture of COM and COD) which were less recurrent and 
type IIa + IVa1 (COD and carbapatite) stones which were 
significantly more recurrent.
Regarding stones composed primarily of forms of cal-
cium phosphate, types IVa1 and IVa2 (both types of car-
bapatite) were very different, the latter being significantly 
more recurrent than the mean of all stones from men and 
women, suggesting the possibility of more active meta-
bolic processes driving this morphological form. Type IVd 
(brushite) was also significantly more recurrent in both 
sexes, consistent with the high recurrence rate of this stone 
type reported in American studies [18–20].
Stones composed of uric acid of type IIIb (not type IIIa, 
often related to stasis) or cystine were significantly more 
recurrent than the mean for all stones, consistent with these 
stones resulting from metabolic processes more active than 
those that drive the formation of common calcium stones.
Influence of Randall’s plaque (RP)
As seen in Table  5, calcium oxalate stones developed 
from RP actually seem to exhibit a slight tendency to be 
more recurrent than stones formed by other mechanisms 
(p = 0.02), with a significant difference according to the 
gender of patients. In men, 41% of stones with an RP were 
recurrent by comparison with 38.6% of stones without any 
RP (p < 0.01). No significant difference was found in stones 
Table 2  Mean age (years ± SD) at the first stone episode according to the stone composition
*COM = calcium oxalate monohydrate − COD = calcium oxalate dihydrate
Main component Males Females All p value
M vs F
N Age N Age N Age
Dihydroxyadenine 15 7.2 ± 9.3 6 29.0 ± 17.3 21 15.7 ± 16.6 < 0.01
Cystine 43 26.5 ± 20.1 51 27.7 ± 16.3 94 27.1 ± 18.2 NS
Octacalcium phosphate pentahydrate 16 25.6 ± 18.4 18 31.0 ± 13.2 34 28.6 ± 15.9 NS
Whitlockite 21 25.1 ± 19.2 22 37.4 ± 16.3 43 31.4 ± 18.4 < 0.05
Ammonium hydrogen urate 48 25.4 ± 27.1 35 43.7 ± 19.8 83 33.1 ± 26.1 < 0.001
Weddellite (COD)* 3440 41.0 ± 14.0 1039 39.7 ± 16.1 4469 40.7 ± 14.6 < 0.05
Brushite 162 42.8 ± 16.8 59 38.2 ± 16.2 221 41.6 ± 16.9 NS
Carbapatite 1064 39.4 ± 22.9 1702 43.1 ± 16.9 2766 41.7 ± 19.6 < 0.001
Amorphous carbonated calcium phosphate 17 37.7 ± 30.1 29 44.4 ± 25.1 46 41.9 ± 27.1 NS
Struvite 157 44.2 ± 26.5 205 47.2 ± 21.3 362 45.9 ± 23.7 NS
Whewellite (COM)* 7890 48.8 ± 14.4 3383 47,4 ± 16.5 11,273 48.4 ± 15.1 < 0.01
Uric acid dihydrate 192 58.3 ± 12.9 40 62.9 ± 14.0 232 59.1 ± 13.3 NS
Uric acid anhydrous 1080 62.8 ± 14.6 366 61.8 ± 15.1 1446 62.5 ± 14.9 NS
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Fig. 2  Age distribution of patients at the onset of COM or COD stone disease in both genders
from women. However, differences exist regarding the stone 
type. For example, COM stones of type Ia developed from an 
RP appear significantly more recurrent than COM stones of 
type Ia without RP in men (38.1 vs 33.5%, p < 0.001) with 
only a trend in women (32.1 vs 28%, p = 0.07). In addition, 
stones of mixed types I + II and II + I are significantly more 
recurrent than type Ia stones in men in both groups of stones 
with and without RP and in women in the group of stones 
without RP.
Discussion
Stone disease is a very common finding in industrialized 
countries and is constantly increasing as revealed by epi-
demiological studies [21–23]. In most cases, it is a conse-
quence of dietary imbalance and/or chronically insufficient 
water intake. In general, the correction of these factors 
should prevent stone recurrence. However, among stone dis-
eases, metabolic forms exist that expose the patient to mul-
tiple recurrences of calculi with the possible consequence 
of altering the kidney function and, sometimes, inducing 
end-stage renal failure. These may result from inherited or 
acquired pathologies, the diagnosis of which is of crucial 
importance to treating them and reducing the risk of stone 
recurrence and crystallization in the kidney. Stone analysis 
at the first episode is one method for the early detection of 
stone diseases which are prone to recur. As shown in the 
present study, there are great differences in terms of stone 
recurrence risk according to both stone composition and 
morphology.
Onset of stones
The mean age at the onset of the disease, as revealed by 
a stone episode, varied in relation to the stone compo-
sition. The earliest component found was dihydroxyad-
enine, which corresponds to an adenine phosphoribosyl-
transferase deficiency, an inherited autosomal disease 
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Fig. 3  Age distribution of patients at the onset of uric acid stones in 
men and women
Table 3  Frequency of stone 
recurrence according to the 
stone composition
(1) ACCP = amorphous carbonated calcium phosphate
*p < 0.05; **p < 0.01; ***p < 0.00001 vs females
a p < 0.05; bp < 0.01; cp < 0.001; dp < 0.0001; ep < 0.00001 vs mean recurrence for a given gender or by com-
parison to the whole series
Component Males Females Total
N % N % N %
ACCP(1) 8 32.0 13 30.2 21 30.9
Whitlockite 10 32.3 14 38.9 24 35.8
Whewellite (COM) 5241 39.5***,e 1768 34.1e 7013 38.0e
Struvite 143 47.0** 121 36.7 264 41.6
Presence of struvite 492 44.9*** 526 36.5 1018 40.1
Ammonium Urate 28 36.8 32 47.1 60 41.7
Weddellite (COD) 2883 45.2*** 625 37.2 3508 43.5a
Carbapatite 1022 48.8***,e 1143 39.9 2165 43.6a
Uric acid anhydrous 1193 52.1*,e 329 46.8c 1522 50.9e
Uric acid dihydrate 198 50.6 a 50 55.6b 248 51.6c
Octacalcium phosphate 28 63.6*,a 15 45.5 43 55.8
Brushite 479 75.7e 143 70.8e 622 74.5e
Cystine 378 90.9e 293 86.7e 671 89.0e
Dihydroxyadenine 19 95.0d 7 100b 26 96.3e
All stones 11,702 44.4*** 4634 38.9 16,341 42.7
often inducing end-stage renal failure when undiagnosed 
[24–27]. Unexpectedly, there was a strong difference in 
the onset of the disease according to gender, males being 
prone to develop stones earlier than females. Perhaps a 
bias exists due to the small number of cases. Coming next 
were cystine stones which, despite the fact that they result 
from a congenital defect in tubular transport, in contrast to 
dihydroxyadenine stones, are known to make their appear-
ance in the second or third decade of life [28, 29]. Indeed, 
the data here suggest that some cystine stone formers do 
not present their first stone until the seventh decade of 
life. The next earliest component was octacalcium phos-
phate, an instable form of apatite able to convert to it in 
some months. The next component was whitlockite, an 
infrequently found form of calcium magnesium phosphate, 
which, in our experience, is essentially a marker of infec-
tion [30].
Ammonium hydrogen urate stones were found signifi-
cantly earlier in men than in women. A possible explana-
tion is related to stones induced by urea-splitting bacteria. 
Such stones contain ammonium salts such as struvite and/or 
ammonium urate. They are especially frequent in very young 
boys (at the time where uricosuria is still elevated) and more 
later in life for women.
COD, found as the first stone at the mean age of 40 years, 
is a rather calcium-dependent form of calcium oxalate stone, 
mainly observed in hypercalciuric states [12, 13, 31]. Four 
forms of phosphate stone, including amorphous carbonated 
calcium phosphate, carbapatite, brushite and struvite, also 
appeared at an average first age in the forties. Interestingly, 
the average age of onset of the most common form of stone, 
COM, was later than all of these, at 48 years of age. Of note, 
in Japan, Koide et al. reported in the eighties that patients 
who form COD stones are different from those who form 
Table 4  Frequency of stone 
recurrence according to the 
morphological type of the stone
(1) Complete description of the stone types is given in Daudon et al. [9, 10]
*p < 0.05; **p < 0.01; ***p < 0.00001 vs females
a p < 0.05; bp < 0.01; cp < 0.001; dp < 0.0001; ep < 0.00001 vs mean stone recurrence for a given gender or 
for total
Morphological  type(1) Males Females Total
N % N % N %
Calcium oxalates
 Ia 1735 35.9***,e 499 29.8d 2234 34.3e
 Ib 58 26.1c 25 30.9 83 27.4d
 Ic 29 85.3e 13 76.5b 42 82.4e
 Id 66 40.0 43 46.2 109 42.3
 Ie 44 54.3 26 48.2 70 51.9
 Ia + IIa 424 41.7 147 38.6 571 40.8
 Ia + IIb 1051 39.5**e 306 32.1b 1359 37.6e
 IIb + Ia 1433 44.4** 380 38.7 1813 43.1
 IIa 773 44.6** 161 37.6 934 43.2
 IIb 400 39.1a 86 25.4 486 38.4
 IIa + IVa1 959 48.5 **,b 286 40.8 1245 46.5c
 IIb + IVa1 213 39.1 99 40.4 312 39.5
 Ia + IIa + IVa1 682 46.4** 326 36.8 1008 42.8
Calcium phosphates
 IVa1 (w/o struvite) 110 47.8**,a 125 38.0 235 42.0
 IVa2 26 70.3a 53 84.1e 79 79.0e
 IVb 221 48.3*** 335 35.2a 556 39.4b
 IVd 229 73.6e 73 68.9e 302 72.4e
Struvite (magnesium ammonium phosphate hexahydrate)
 IVc 29 53.7 17 32.7 46 43.4
Uric acids
 IIIa 186 45.7 39 50.7a 225 46.5
 IIIb 840 53.2**,e 230 47.2b 1070 51.8e
Cystine
 Va 312 90.7 233 84.7e 545 88.1e
 Vb 20 100 7 100b 27 100e
Fig. 4  Recurrence of stones by 
morphology. Type Ia and type 
Ic stones are made of pure or 
nearly pure calcium oxalate 
monohydrate, which accounts 
for more than 95% of the stone 
mass. Type IVa1 and type 
IVa2 stones are made of nearly 
pure calcium orthophosphates 
(mainly carbapatite), which 
account for more than 90% of 
the stone mass. *Significantly 
different from mean of all 
stones, p < 0.01, with mean 
shown by horizontal line
Table 5  Comparison between umbilicated stones or not
Stones of mixed types I + II include stones with various subtypes where COM was the main crystalline phase of calcium oxalate. By contrast, 
stones of mixed types II + I include stones with various subtypes where COD was the main crystalline phase of calcium oxalate. As shown in the 
table, the recurrence rate is not the same according to the main crystalline phase of calcium oxalate: when COD is the main crystalline phase, the 
stones are commonly more recurrent by comparison with type Ia stones used as a reference
*p = 0.02; **p < 0.01; ***p < 0.001; ****p < 0.0001 vs non-umbilicated stones
† p < 0.05; ††p < 0.01; †††p < 0.001; ††††p < 0.0001 vs type Ia stones for a given gender
a p < 0.05; bp < 0.01; cp < 0.001; dp < 0.0001 vs females
x p < 0.01; xxp < 0.0001 vs mean occurrence of stone recurrence for a given gender
Morphological type Males Females Total
First stone Recurrence First stone Recurrence First stone Recurrence
Umbilicated stones with Randall’s plaque
 Type Ia alone 1549 954 (38.1)***,b,xx 501 237 (32.1)x 2050 1191 (36.7)****
 Mixed types I + II 869 650 (42.8)**,b,†† 332 171 (34.0) 1201 821 (40.6)††
 Mixed types II + I 360 328 (47.7) c,†††† 108 57 (34.6) 468 385 (45.1)††††
 Total 2778 1932 (41.0)**,d,xx 941 465 (33.1)xx 3719 2397 (39.2)*,xx
Stones without any umbilication nor Randall’s plaque
 Type Ia alone 1551 781 (33.5)b 674 262 (28.0)xx 2225 1043 (31.9)xx
 I + II 1332 825 (38.2)a,xx,††† 548 282 (34.0)x,†† 1880 1107 (37.1)xx,††††
 II + I 1433 1105 (43.5)a,†††† 493 323 (39.6)†††† 1926 1428 (42.6)††††
 Total 4316 2711 (38.6)c,xx 1715 867 (33.6)xx 6031 3578 (37.2)xx
COM stones and that COD stones were observed earlier than 
COM stones in Japanese patients [32]. Finally, the age of 
first occurrence of uric acid stones was much later, at about 
60 years of age, probably related to the increased occurrence 
at older ages of overweight, metabolic syndrome, and type 
2 diabetes [33, 34].
Stone recurrence
A stone recurrence rate around 50% is commonly accepted 
in the literature, both in children and adults [35, 36]. How-
ever, no data are reported regarding crystalline phases of the 
stones. Among the stone mineral types seen with the lowest 
percentages of recurrence (Table 3), three were phosphate 
stones composed of minerals that have been shown to be 
related to urinary tract infection (whitlockite, amorphous 
carbonated calcium phosphate, and struvite) [30]. These 
results seem reasonable because stones occurring due to 
infection are not likely to recur if the infection is successfully 
treated. Within the range of recurrence frequency of infec-
tion stones, however, are also stones composed of COM, for 
which the underlying cause for stone formation is generally 
a hyperoxaluria of moderate degree [12, 37, 38]. Thus, it is 
apparent that COM stones are less likely to be recurrent than 
are other calcium stones whose origins are also metabolic, 
but for which the endogenous biochemical abnormalities are 
more marked. It is also interesting to note that the percentage 
of recurrent COM stones is less than the mean percentage for 
all recurrent stones, for both men and women.
If we consider that physicians propose for preventing 
recurrence of all urinary stones adequate dietary advices or 
medical treatment according to the stone composition (cal-
cium stone, uric acid stone, cystine stone, struvite stone…), 
it is unlikely that stone recurrence might be a consequence of 
an inappropriate medical care. Obviously, we cannot exclude 
that patients were not compliant with physician recommen-
dations. However, there is no evidence that such default 
of compliance may depend on stone type. Thus, intrinsic 
characteristics of crystalline phases or of stone morphol-
ogy appear highly suggestive for different courses of stone 
disease.
Among the four compositions that are least recurrent, 
struvite is obviously special. Although in women the per-
centage of recurrent stones composed of struvite was slightly 
less than the mean for all stones, struvite stones were con-
siderably more recurrent in men. This difference may occur 
for a number of reasons. First, anatomical and disease con-
ditions could make the formation of struvite stones more 
favorable in men, especially prostatic hypertrophy, which 
often causes incomplete emptying of the urinary bladder. 
However, in our experience, only one-third of bladder stru-
vite stones associated with prostate hypertrophy were recur-
rent. Another reason for the higher incidence of recurrent 
struvite stones in men could be that infection is less expected 
in men, and thus not recognized and promptly treated as 
often as it is in women. In any case, when one examines 
the epidemiologic changes in stones in France over the 
past 30 years, one can see that the frequency of infection 
stones has fallen dramatically for women—3.5-fold—while 
that for men has dropped by only 20% [39]. Of note, recent 
epidemiological data suggest that struvite stones could be 
more frequent in recent decades by comparison to previous 
reports, especially in men [40].
Ammonium urate was found to be slightly less recurrent 
by comparison to the whole series. It was a more recurrent 
component in women than in men. Although it is always 
found with hyperuricosuria, other factors are necessary to 
its formation and it can appear in the context of different 
pathologies (anorexia and laxative abuse, infection with 
urea-splitting organisms, poor animal protein diet and 
chronic diarrhea, etc. [41, 42]).
Among the more recurrent compositions, octacalcium 
phosphate and the two forms of uric acid are at levels just 
slightly above the average percentage for all stones. These 
stones include a species that is at least suspected of being 
calcium-dependent (octacalcium phosphate [30, 43]), and 
two species (uric acid, both anhydrous and dihydrate) that 
are frequently associated with metabolic syndrome and dia-
betes [33, 34, 44].
The three most recurrent species were found to be dihy-
droxyadenine, cystine and, surprisingly, brushite. The first 
two crystalline species are due to well-defined inherited dis-
orders. In contrast, brushite in stones is not recognized as 
a marker of any genetically linked pathology; yet the rapid 
growth of brushite stones leads to recurrence rates similar 
to those of stones formed as the result of genetic disorders, 
with 75% of brushite stones coming from patients who have 
already had at least one stone episode. Moreover, patients 
with brushite stones very often have had repeated stone epi-
sodes and frequently are found to have multiple stones with 
each incidence and a higher number of urological procedures 
[18–20]. Brushite stones are also classed, along with those 
of cystine, as the stones most difficult to break [45]. These 
results suggest the need for more sophisticated studies of 
the metabolic disorders present in the patients who produce 
brushite stones. Indeed, the incidence of brushite stones has 
increased considerably over the past years, from 0.8% of all 
stones in 1980 to 2.2% today in France [46] and from 1.7 to 
4.1% in the United States [47].
If one compares the recurrence rate of stones between 
men and women, one can state that all stone types recur 
more frequently in men, with the exception of ammonium 
urate, uric acid dihydrate, brushite, and the stones of an 
obviously genetic origin (cystine and dihydroxyadenine) 
for which one observes no significant difference in recur-
rence rates between the sexes. These data suggest a role 
for environmental factors, particularly nutritional differ-
ences, for those stone types that are more recurrent in men; 
conversely, endogenous metabolic disorders, congenital or 
acquired, for which stone occurrence is linked to the nature 
of the metabolic abnormality rather than to environmental 
factors, seem to be more important for those stone types for 
which recurrence does not differ between the sexes.
Relationship between stone recurrence 
and morphology
A unique aspect of the present study is the examination of 
relationships between stone recurrence and morphologies 
of stones, which can differ even within the same compo-
sitional class. For example, even though the overall recur-
rence rate of COM stones was relatively low, the recurrence 
rates of some morphologies of COM were significantly 
higher (Fig. 4). We are aware of the relatively small number 
of stones regarding some morphological types. However, 
despite this limitation, the significant differences between 
stones types for the same crystalline species may alert us on 
special risk factors related to such stone types. Thus, recog-
nition of more recurrent morphologies of COM in a patient 
could be of benefit in diagnosis and treatment.
Among stones composed mainly of COD (type II), the 
sub-type IIb was found to be significantly less recurrent than 
were the sub-types IIa or IIa + IVa1, the latter of which was 
more recurrent than the mean for all stones, whether just for 
men or for the entire series. However, these recurrence rates 
among morphological forms of COD stones—in contrast to 
what was observed for COM—are relatively small, perhaps 
reflecting the overall influence of hypercalciuria in the for-
mation of this mineral type [11–13].
Among stones composed mainly of carbapatite, the mor-
phology of type IVa2 (stones with an irregular but shiny 
surface, with subsurface cracks visible beneath the trans-
lucent surface coat) correlated with a higher incidence of 
recurrence than for other carbapatite stones. In our experi-
ence, these stones are associated with all conditions of dis-
tal tubular acidosis, i.e., Sjögren syndrome, inherited renal 
tubular acidosis, medullary sponge kidney [48]. In contrast, 
carbapatite morphology IVb (heterogeneous surface com-
posed of incomplete layers with varying texture and color, 
including bumpy/rough regions) was less recurrent, espe-
cially in women. This morphology is frequently associated 
with infection [9], so the difference in its recurrence between 
men and women could be related to a poorer detection and/
or a less effective medical surveillance for men in this con-
text than for women.
At last, we found differences in the occurrence rate 
according to the presence or not of a RP. It was shown 
since more than twenty years that RP is now the main fac-
tor involved in initiating calcium oxalate stone formation 
[49–51]. Based on visual inspection of papillae thanks to 
ureteroscopy, it was reported that most calcium stone form-
ers exhibit multiple papillary calcifications [52]. On the 
other hand, it was reported a higher occurrence of kidney 
stones related to the papillary coverage by Randall’s plaque 
[53]. Thus, it would be expected that stones developed 
from RP should be especially at risk to recur. As shown 
in Table 5, the difference between stones developed from 
RP and similar stones developed without RP is not so high. 
However, when stone types are taken into account, calcium 
oxalate stones made of a combination of COM and COD 
(mixed types I + II and II + I) are significantly more recur-
rent than stones exclusively made of COM, suggesting that 
metabolic differences could exist between patients producing 
these different types of stones. Further studies are needed to 
confirm such hypothesis.
In conclusion, recurrence of urolithiasis is quite variable, 
being correlated with not only the crystalline composition 
of the stones, but also with morphological types and cer-
tain other structural characteristics. Among calcium oxa-
late stones, COD stones recur considerably more often than 
do stones composed of COM. Among calcium phosphate 
stones, octacalcium phosphate and, above all, brushite stones 
are more recurrent than other phosphate stone compositions. 
Brushite stones are especially notable in this regard, not only 
for their high degree of recurrence, but also because they 
tend to recur as multiple stones and because the underlying 
causes of brushite stone formation have not yet been clearly 
established. Our results also show that the morphology of 
the stones is important. Thus, it would seem appropriate for 
clinical work not to limit stone analysis to stone composition 
only, but also to take into consideration the morphology of 
the stone, as this can help in diagnosis and in pinpointing 
the factors that are causative for stone formation, so that 
better measures for prevention of stone recurrence can be 
prescribed for each patient.
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